Write in a clean editor, then format for European Clinical Respiratory Journal in one click — DocuGuru applies the official Taylor & Francis template with author–year references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.
European Clinical Respiratory Journal is a peer-reviewed journal published by Taylor & Francis, covering Chronic Obstructive Pulmonary Disease (COPD) Research, Asthma and respiratory diseases, Respiratory and Cough-Related Research.
| Publisher | Taylor & Francis |
|---|---|
| Reference style | Author–year (Chicago, T&F) Author–year — (Smith, 2023) in the text Smith, Ada, Ben Jones, and Cara Lee. 2023. "A Representative Article Title." European Clinical Respiratory Journal 12 (3): 45–58.
Formats any DOI in European Clinical Respiratory Journal style. No sign-up. |
| Publishes research in | Chronic Obstructive Pulmonary Disease (COPD) Research Asthma and respiratory diseases Respiratory and Cough-Related Research Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis Respiratory Support and Mechanisms |
| ISSN | 2001-8525 |
| Citation impact (2-yr) | 1.39 |
| h-index | 32 |
| i10-index | 132 |
| Total citations | 4,583 |
| Article processing charge | $1,895 |
| Open access | Yes |
| Top institutions publishing here | Aarhus University Hospital |
| Journal website | www.tandfonline.com |
| You get | A submission-ready PDF and the editable LaTeX source — ready to submit. |
Citations each year’s papers have accumulated so far — the most recent years are still building up.
The atopic diseases - atopic dermatitis, asthma, and hay fever - pose a great burden to the individual and society, not least, since these diseases have reached epidemic proportions during the past decades in industrialized and, more recently, in developing countries. Whereas the prevalence of the atopic diseases now seems to have reached a plateau…
The small airways are defined as those less than 2 mm in diameter. They are a major site of pathology in many lung diseases, not least chronic obstructive pulmonary disease (COPD) and asthma. The small airways are frequently involved early in the course of these diseases, with significant pathology demonstrable often before the onset of…
The terms 'exercise-induced asthma' (EIA) and 'exercise-induced bronchoconstriction' (EIB) are often used interchangeably to describe symptoms of asthma such as cough, wheeze, or dyspnoea provoked by vigorous physical activity. In this review, we refer to EIB as the bronchoconstrictive response and to EIA when bronchoconstriction is associated with asthma symptoms. EIB is a common occurrence…
Asthma runs in families, and children of asthmatic parents are at increased risk of asthma. Prediction of disease risk is pivotal for the clinician when counselling atopic families. However, this is not always an easy task bearing in mind the vast and ever-increasing knowledge about asthma genetics. The advent of new genotyping technologies has made…
Three recent clinical trials on the pharmacologic treatment of idiopathic pulmonary fibrosis (IPF) mark a new chapter in the management of patients suffering from this very severe fibrotic lung disease. This review article summarizes the published investigations on the preclinical studies of three novel IPF drugs, namely pirfenidone, nintedanib, and N-acetylcysteine (NAC). In addition, the…
